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Abstract
Background. Historically, the operative mortality associated with hepatic abscess was /50%. More recently, patients have
been treated with percutaneous drainage; however, those failing conservative management are treated operatively. Our aim
was to evaluate the outcome of operation for hepatic abscess in those failing conservative treatment or in those presenting as
a surgical emergency. Patients and methods. This was a retrospective review of patients undergoing operation for hepatic
abscess at the Mayo Clinic, Rochester, Minnesota from 1990 to 2003. Results. Of 288 patients diagnosed with hepatic
abscesses, 32 required operation. Percutaneous drainage was the initial treatment in 15 (47%). The remaining 17 were
initially managed with operation. Operative indication was septic shock (41%), failed nonoperative management (31%),
and failure to make a diagnosis (28%). Operation was drainage (62%) or resection (38%). The morbidity and mortality
rates were 41% and 15.6%, respectively. Factors associated with increased operative mortality were shock (p/0.04),
INR/1.5 (p/0.03), WBC/15 000 (p/0.04), AST/150 U/L (p/0.01), alkaline phosphatase /500 U/L (p/0.03),
positive blood cultures (p/0.03), total bilirubin /2.0 mg/dl (pB/0.01), multiple abscesses (p/0.01), and second
operation (pB/0.001). Factors not associated were extent of resection (p/0.10), peritonitis (p/0.10), intensive care
admission (p/0.10), polymicrobial infection (p/0.10), and blood transfusion (p/0.10). Conclusion. Operative
intervention is avoided in 89% of patients with hepatic abscess. Septic shock is the most common reason for operation.
Patients with septic shock, INR/1.5, WBC/15 000, AST/150 U/L, total bilirubin /2.0 mg/dl, positive blood cultures,
or alkaline phosphatase /500 U/L have increased mortality when undergoing operation for hepatic abscess.
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Introduction
Hepatic abscess is a rare disease of varying patho-
physiology. The original report by Ochsner described
a series of pyogenic hepatic abscesses and an
associated high mortality rate. The hepatic abscess
was most commonly secondary to portal pylephlebi-
tis, usually in association with acute appendicitis [1].
In more recent decades, appendicitis, and the ensuing
pylephlebitis, as a cause has decreased, while a biliary
source now accounts for about 30% of pyogenic liver
abscesses [24]. Other sources include direct
extension, or via the hepatic artery, or secondary to
trauma. A pyogenic abscess is the most common
form, accounting for 80% of cases, while amebic and
fungal infections collectively comprise about 20%
of cases. The causative organism associated with
pyogenic abscesses is often gram-negative bacteria
alone or with an anaerobic superinfection. Entamoeba
histolytica is causative of amebic abscess, and 20%
of these may have bacterial superinfection [5].
Candida species cause the majority of fungal hepatic
abscesses.
With improved imaging, antibiotic and surgical
therapy, intensive care monitoring, and percutaneous
radiologic drainage techniques, the morbidity and
mortality rates associated with hepatic abscess have
been dramatically decreased. Prior to surgical drai-
nage, a hepatic abscess was always fatal for the
patient. The use of surgical drainage and intravenous
antibiotics initially reduced the mortality rate to about
50%. Although much progress has been made, over
the past two decades, mortality rates have not fallen
below 10% [68].
Furthermore, percutaneous techniques have be-
come very successful in treating this disease [911].
Most cases of hepatic abscess are initially treated by a
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radiologist, and perhaps those reaching the general
surgeon are later in the progress of the disease, in
septic shock, or are more complex patients, such
as those with multiple, loculated, or bilobar abscesses.
Therefore, surgeons need to be skilled in the
management of patients with hepatic abscess, both
from a critical care as well as operative standpoint.
Patients and methods
All patients undergoing operation for hepatic abscess
at the Mayo Clinic, Rochester, Minnesota between
1990 and 2003 were included in this retrospective
review. Clinicopathologic factors were analyzed to
determine those factors that significantly affected
morbidity and mortality.
Results
In all, 288 patients diagnosed with hepatic abscess
were admitted to the Mayo Clinic between 1990 and
2003. Operative intervention was required in 32
patients (11%). This population comprised 19 males
and 13 females (mean age 54 years).
Clinical presentation
A normal physical exam was the most common
finding at presentation (10 patients). Peritonitis and
hepatomegaly were each present in six patients (19%).
Fever and jaundice were seen in four (12.5%) and two
(6%) patients, respectively. Septic shock was defined
as hypotension requiring aggressive fluid resuscitation
or pharmacologic pressors. Likewise, a patient
presenting in extremis was categorized with septic
shock. Thirteen patients (41%) presented with septic
shock. Fifteen patients underwent percutaneous
drainage prior to operation (47%). Malignancy had
previously been diagnosed in six (19%) patients and
four (12.5%) were being treated with oral steroids.
Six patients (19%) had undergone previous liver
operation. Blood cultures were positive at admission
in 13 patients (41%).
Laboratory values (Table I)
Microbiologic data were available for 30 of the
patients in this series. Eleven patients (37%) were
infected with one organism while nine patients (30%)
had polymicrobial infections. A sterile abscess
was diagnosed in eight patients (27%). Seven
gram-positive, 13 gram-negative, and 7 anaerobic
organisms were isolated. Of the 24 patients with
infected abscesses, the main isolates were Klebsiella
species (25%), while Escherichia coli was found in
12.5%. Candida was isolated in one patient.
Radiologic data
Plain abdominal radiographs were performed in 26
patients. The majority of these were normal (17,
65%), while a right pleural effusion (6, 23%) or
pneumobilia (3, 12%) was diagnosed less frequently.
Transabdominal ultrasound (US) and computed
tomography (CT) were done in 15 and 28 patients,
respectively. Both modalities demonstrated 100%
sensitivity. The majority of patients had a single
hepatic abscess (22, 69%), although 10 (31%)
patients presented with multiple abscess cavities. A
right hepatic lobe abscess was diagnosed in 18
patients (56%). A left abscess or bilobar abscesses
were found in 11 (34%) and 3 (9%) patients,
respectively.
Operative data
Thirteen surgeons operated on 32 patients with
hepatic abscess during the study period. Reasons for
operation were septic shock, occurring in 13 (41%)
patients, multiorgan system failure (10%), failure of
medical management (36%), and failure to make
diagnosis (7%). The most common etiology was
a biliary source (15, 47%), either secondary to
cholangitis (5) or direct extension secondary to acute
cholecystitis (10). Other etiologies include a portal
venous source (5, 16%), dental caries (3, 9%), and
malignancy (2, 6%). Seven patients (22%) developed
a cryptogenic hepatic abscess.
Table I. Laboratory values.
Laboratory value Units Normal range Median Range Number abnormal
Total bilirubin mg/dl 0.11.0 1.6 0.16.0 11 (34%)
Alkaline phosphatase U/L 45115 632 1012488 30 (94%)
Albumin g/dl 3.55.0 3.3 2.44.3 9 (28%)
AST U/L 1231 180 132131 23 (72%)
Creatinine mg/dl 0.91.4 1.3 0.55.0 7 (22%)
WBC count /109/L 3.510.5 15.8 4.351.3 24 (75%)
Hemoglobin g/dl 13.517.5 11.1 7.914 29 (91%)
INR 1.3 0.92.5 4 (12.5%)
AST, aspartate aminotransferase; INR, international normalized ratio; WBC, white blood cell.
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Percutaneous drainage was the initial management
in 15 (47%) of the 32 patients; 9 (60%) of
these required operative intervention secondary to
uncontrolled sepsis. The most common operative
treatment consisted only of abscess drainage
(20, 62%); however, hepatic resection was performed
in 12 patients (38%). Resections included five
non-anatomic segmentectomies, four left hepatec-
tomies, and three right hepatectomies.
Morbidity and mortality (Table II)
The mean length of hospital stay was 18 days (range
5102). Seventeen patients (53%) required intensive
care admission. Thirteen patients (41%) required
blood transfusions during the operation or hospital
course. Complications occurred in 13 patients (41%)
and 8 of those patients developed multiple complica-
tions. Six patients developed multiorgan system
failure. Bile leak occurred in two patients and two
developed wound complications. Reoperation was
necessary in six patients (19%).
The operative mortality rate while in hospital or
within 30 days of operation was 15.6% (five patients).
These patients were compared to the group of
survivors in order to determine which factors were
associated with increased operative mortality. Factors
associated with increased operative mortality were
septic shock (p/0.04), an international normalized
ratio (INR)/1.5 (p/0.03), white blood cell (WBC)
count /15 000 (p/0.04), aspartate aminotransferase
(AST)/150 U/L (p/0.01), alkaline phosphatase
/500 U/L (p/0.03), positive blood cultures
(p/0.03), total bilirubin /2.0 mg/dl (pB/0.01),
multiple abscesses (p/0.01), and need for a second
operation (pB/0.001). Factors not associated
with increased surgical mortality included extent of
resection (p/0.10), peritonitis (p/0.10), intensive
care unit (ICU) admission (p/0.10), polymicrobial
infections (p/0.10), and blood transfusion
(p/0.10). Also, immunosuppression (defined as
oral steroid use or presence of malignancy) did not
significantly affect survival (p/0.10).
Discussion
Hepatic abscess is a disease with varying and evolving
pathophysiology and has been solely treated
operatively until the last two decades. Originally
described as a disease secondary to pyogenic portal
spread [1], this has shifted and, as in this series, a
biliary source is now the cause of hepatic abscess in
the majority of cases [24,10,11]. A portal source was
found in only 16% of cases and the source was
cryptogenic in 22%, which is similar to other series
published in the literature [12]. A polymicrobial
infection was seen in 30% of cases, while a single
bacterial or fungal agent was seen in 37%. Most of the
infections were gram-negative, although some were
also fungal, amebic, gram-positive, or anaerobic.
While this variety is seen throughout the literature,
most operative series focus on pyogenic hepatic
abscesses. The series presented demonstrates that
surgeons should be aware of different causative factors
for hepatic abscess as well as their most successful
treatments.
Patients with hepatic abscess present to medical
care by a variety of paths. In this series, the majority of
patients presented with a normal physical exam;
however, a significant percentage presented with signs
or symptoms of sepsis or an abdominal surgical
emergency. As surgeons, attention needs to be direc-
ted at those patients presenting with physical signs
warranting imaging or invasive therapies. Laboratory
values are often abnormal in those with hepatic
abscess. The 41% of patients in this series
that presented with positive blood culture were
significantly more likely to be an operative mortality
(p/0.03). Also, those with elevated liver enzymes,
specifically total bilirubin (pB/0.01), AST (p/0.01),
and alkaline phosphatase (p/0.02) and those with
septic shock (p/0.04), occurring in 41%, were more
likely to be an operative mortality. Based on these
findings, we conclude that when a patient presents
with hepatic abscess, along with septic shock, positive
blood cultures, or increased liver enzymes, surgeon
involvement and acuity of care should be raised.
Radiologic imaging at presentation varied depend-
ing on the severity of the patient’s condition. The
majority of plain radiographs were normal. CT was
most commonly performed, although about half of
Table II. Factors evaluated for operative mortality in patients with
hepatic abscess.
Factor Number of patients p value
INR/1.5 4 0.03
WBC/15 000 14 0.04
AST/150 U/L 5 0.01
AP/500 U/L 12 0.03
Positive blood culture 13 0.03
Septic shock 13 0.04
Total bilirubin /2.0 mg/dl 11 B/0.01
Multiple abscesses 10 0.01
Second operation 6 B/0.001
Extent of resection /0.10
Drainage 20
Segmentectomy 5
Left hepatectomy 4
Right hepatectomy 3
Peritonitis 6 /0.10
ICU admission 17 /0.10
Polymicrobial abscess 9 /0.10
Blood transfusion 13 /0.10
Percutaneous drainage 15 /0.10
Immunosuppression 10 /0.10
AP, alkaline phosphatase; AST, aspartate aminotransferase; ICU,
intensive care unit; INR, international normalized ratio; WBC,
white blood cell.
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the patients underwent transabdominal US. Both of
these modalities had 100% sensitivity in the diagnosis
of hepatic abscess. Excellent results with diagnosis
and management of hepatic abscess have also been
documented in the literature [13]. During the past
two decades, improvements in radiologic imaging and
percutaneous techniques have allowed a significant
percentage of hepatic abscesses to be treated without
operation [68,13,14]. As seen in this series, most
patients were initially managed with percutaneous
drainage. This treatment was vastly successful, in that
of the 288 patients diagnosed with hepatic abscess,
only 32 eventually required operation. Conversely, of
the 32 undergoing operative management, 60% failed
percutaneous treatment. Attempt at percutaneous
treatment was not predictive of operative mortality
(p/0.32).
The hepatic abscess was most often found in the
right hepatic lobe (56%), and a left lobe abscess or
bilobar abscesses were found in 34% and 9%,
respectively. This trend is similar to that reported
previously [15]. The majority of patients presented
with a single cavity, but 31% had multiple abscesses
diagnosed, and this trend is reflected in the literature
[15]. In this study, the presence of multiple abscesses
(p/0.01) was associated with increased operative
mortality. The operative management consisted of
evacuation and external drainage in the majority of
cases (62%), but the remainder required resection. A
segmentectomy or wedge resection was performed in
five patients, and formal right or left hepatectomies
were performed in three and four patients, respec-
tively. Extent of operation did not affect the mortality
rate (p/0.10). Therefore, if the abscess is adequately
relieved with percutaneous drainage, operative drai-
nage, or operative excision, outcome is good.
Following operative management of hepatic
abscess, the patients experienced a significant
complication rate (41%). Of these, 62% developed
multiple complications and 46% developed multi-
organ failure. Reoperation was necessary in 19%,
and this was associated with increased mortality
(pB/0.001), likely secondary to the poor physiologic
condition of the patient. However, the need for blood
transfusion (p/0.10) and intensive care admission
(p/0.10) were not associated with increased
mortality.
The Center for Patient Oriented Research at the
Mayo Clinic was utilized for statistical analysis in
this review. Due to small sample size in the operative
mortality group, it was not possible to achieve
a multivariate analysis of significant factors. We
understand that this is a weakness of this review
and, once larger numbers are accrued, a multivariate
model will be established.
Conclusion
Hepatic abscess is a disease of varying pathophysio-
logy. Advancements in radiologic imaging and
minimally invasive therapies have reduced the
morbidity and mortality associated with hepatic
abscess. However, as in this series, a significant
amount of patients will present with diffuse disease,
in septic shock, or have a physical exam consistent
with a surgical emergency. According to the data
presented, elevation of hepatic enzymes, bilobar or
multiple abscesses, septicemia, septic shock, and need
for a second operation were associated with operative
mortality. Patients with these findings need to be
aggressively monitored and early surgical consultation
and intervention is warranted.
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